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Abstract
We performed a whole-genome association study of rheumatoid arthritis susceptibility using
Illumina 550k single-nucleotide polymorphism (SNP) genotypes of 868 cases and 1194 controls
from the North American Rheumatoid Arthritis Consortium (NARAC). Structured association
analysis with adjustment for potential population stratification yielded 200 SNPs with p < 1 × 10-8
for association with RA, all of which were on chromosome 6 in a 2.7-Mb region of the major
histocompatibility complex (MHC). Given the extensive linkage equilibrium in the region and
known risk of HLA-DRB1 alleles, we then applied conditional analyses to ascertain independent
signals for RA susceptibility among these 200 candidate SNPs. Conditional analyses incorporating
risk categories of the HLA-DRB1 "shared epitope” revealed three SNPs having independent
associations with RA (conditional p < 0.001). This supports the presence of significant effects on
RA susceptibility in the MHC in addition to the shared epitope.
Background
Rheumatoid arthritis (RA) is a chronic systemic auto-
immune disease characterized by damage to synovial
joints as well as extraarticular manifestations. The
strongest known genetic risk factor is the HLA-DRB1
gene on chromosome 6, namely a set of alleles sharing a
common sequence known as the shared epitope (SE) [1].
Recent whole-genome association studies have revealed
new risk genes outside of the HLA region [2-4], and some
studies have also provided evidence of additional
influences from the HLA class III and class I regions
[5,6]. In this analysis we sought first to identify and/or
validate RA risk alleles throughout the genome, and then
to identify independent associations with RA suscept-
ibility in the major histocompatibility complex (MHC)
in addition to the SE.
Methods
Illumina 550k genotyping data from a whole-genome
association study by North American Rheumatoid
Arthritis Consortium (NARAC) [3] was used for this
study as part of the Genetic Analysis Workshop 16;
duplicated and contaminated samples had been
removed previously. Using the computer program
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PLINK [7], subjects were filtered who had less than 90%
genotyping, and single-nucleotide polymorphisms
(SNPs) were filtered that had less than 90% genotyping,
Hardy-Weinberg equilibrium in controls p < 0.0001, or
minor allele frequency (MAF) < 0.05. Using the
computer program EIGENSTRAT [8], population outliers
were removed who were >6 standard deviations from
any of the first five principal components (PCs)
identified in PC analysis.
First we analyzed the whole-genome data using struc-
tured association analyses of EIGENSTRAT; although the
NARAC cases and controls are Caucasian, differences in
intra-European ancestry [9] can produce false-positive
associations. SNPs used for the PCA were filtered to
remove regions of extended local associations (chr 8:
8-12 Mb, chr 6: 24-36 Mb, chr 11: 42-58 Mb, chr 5: 44-
51.5 Mb, and chr 17: 40-43 Mb) and pruned to have r2 <
0.2 within a sliding window of 1 kb with a step size of
100, similar to methods of Fellay et al. [10] and Hom
et al. [11]. We included correction for the first six PCs
(see Results).
We used a conservative genome-wide significance thresh-
old of p = 1 × 10-8. Because all SNPs exceeding this
threshold (i.e., lower p-value) were in the MHC in a
region of extended linkage disequilibrium (LD), we
proceeded with conditional analyses to attempt to
establish signals that were independent of the shared
epitope and each other. We modeled the SE as a multi-
allelic marker with values corresponding to negative,
low-risk, or high-risk. SE alleles were considered high
risk if they were one of DRB1*0401, 0404, 0405, 0408,
or 0409. Table 1 shows the case-control ratios for each
risk category.
Our conditional analyses, using the computer program
Whap [12], proceeded as follows. Starting with the SE as
the top marker, we tested each two-SNP marker (SE plus
each other SNP) for independence of the other SNP; in
particular this uses a likelihood-ratio test to determine
the significance of the difference between the two-SNP
“alternate” model versus the one-SNP (SE in this case)
“null” model. As long as the most significant SNP was
<0.001, we added this best SNP to the list of
independent SNPs, and proceeded to test all three-
marker combinations compared to our best two-SNP
model; and so on with larger haplotypes. In the final list,
we also tested each locus for a significant addition to the
model containing all other top SNPs.
Results
After quality control filtering (above), 486,078 SNPs
remained for the whole-genome analyses. All subjects
had genotyping >90%, and eight controls were removed
as outliers detected by EIGENSTRAT, leaving 868 cases
and 1186 controls for the final analyses. In structured
association analysis with EIGENSTRAT, we corrected for
the first six PCs because the scree graph of eigenvalues
levelled off at the sixth component. PCs one, two, four,
and five were all highly significant in association tests
with cases and controls (all p ≤ 10-8). In this whole-
genome analysis we identified exactly 200 SNPs with
p < 10-8, all between 30.38 Mb and 33.08 Mb in the MHC
region. Table 2 shows the significance of associations in
this dataset for known RA risk alleles outside of the MHC
[2,3,13-17]; for SNPs not in the Illumina 550k panel, there
were perfect proxy SNPs (r2 = 1) in the HapMap CEU
population [18]. Although not reaching our 10-8 threshold,
we observed p-values from 10-5 to 5 × 10-6 for PTPN22 and
TRAF1-C5 SNPs, and p = 0.03 for STAT4. This dataset was
underpowered to detect any of these risk alleles at a
genome-wide level for their published odds ratios (ORs);
for example, we had approximately 70% power to detect
the highest OR of 1.75 (PTPN22, MAF = 11%) at p = 10-8,
and only 50% power to detect the lowest OR of 1.15
(CD40, MAF = 25%) at p = 0.05.
Results of our conditional analyses are shown in Table 3.
Loci are shown in the order added by the algorithm (see
Methods), i.e., rs261946 has the lowest p-value condi-
tional on the SE, rs2074488 has the lowest p-value
conditional on both SE and rs261946, and so on. Out of
the 200 SNPs, three independent signals were evident in
addition to the SE risk levels. One signal is located in the
classical HLA class II region between genes BTNL2 and
HLA-DRA, and two signals are in the classical HLA class I
region (see Figure 1) near TRIM39 and HLA-C.
Table 1: HLA-DRB1 risk levels. Definitions and case-control ratios
for shared-epitope (SE) categories.
DRB1 risk level Definition Case-control ratio
3 = Highest-risk SE DRB1*0401, 0404,
0405, 0408, or 0409
72%-28%
2 = Lower-risk SE Other SE alleles 52%-48%
1 = No SE Not an SE allele 23%-77%
Table 2: Significance of associations with published RA risk alleles





rs2476601 (PTPN22) [16] N/A 5.3 × 10-6
rs7574865 (STAT4) [2] N/A 0.034
rs3761847 (TRAF1-C5) [3] N/A 1.1 × 10-5
rs1953126 (TRAF1-C5) [17] N/A 8.0 × 10-6
rs10499194 (TNFAIP3) [18] rs13192841 0.25
rs6920220 (TNFAIP3) [19] rs6933404 0.17
rs4810485 (CD40) [20] rs1569723 0.12
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Table 4 shows the case-control frequencies and ORs for
the final haplotypes, with the most common haplotype
(ACG-1) as the reference haplotype. The highest-risk
haplotype of these SNPs and the SE level had OR = 27.2
(95% CI, 16.7-44.4) in comparison to OR = 7.3 (95% CI,
4.7-11.1) overall comparing the SE risk levels alone (data
not shown).
Conclusion
In our analysis of the Genetic Analysis Workshop 16
dataset, there was insufficient power to detect known
associations with RA susceptibility at a genome-wide
significance level outside of the MHC; the most
significant association was p = 5.3 × 10-6 for PTPN22.
Clearly, the MHC is the most influential genetic region in
RA susceptibility, but extensive LD makes isolating the
precise loci difficult. We have used conditional analyses
as a tool to investigate the presence of multiple RA risk
factors in the MHC region in addition to the SE. Out of
200 candidate SNPs having unconditional p-values < 10-8,
we have identified an additional HLA class II marker and
two HLA class I markers which have significant associa-
tions with RA susceptibility that are not fully explained
by LD with HLA-DRB1. A better understanding of
these genetic influences can be helpful in elucidating the
complex genetic components of RA.
Table 3: Independent SNPs in conditional analysis of RA susceptibility















Shared epitope (#129) 1.9 × 10-188 N/A N/A 8.6 × 10-74 32,655-32,666 In DRB1
rs261946 (#1) 7.2 × 10-17 1.9 × 10-9 (185) 0.00019 0.0027 30,379 TRIM39
rs2074488 (#5) 2.3 × 10-24 5.0 × 10-12 (151) 6.6 × 10-5 0.0011 31,348 HLA-C
rs2395175 (#119) 1.4 × 10-117 1.9 × 10-80 (2) 0.00031 0.00031 32,513 Between BTNL2
and HLA-DRA
a# indicates marker position in Figure 1. Loci are in order added by conditional algorithm (see Methods).
bFor shared epitope, multi-allelic SNP test in Whap using No-Low-High risk.
cWhap log ratio test using all loci as alternate model versus null model without this locus.
Figure 1
Region with LD of SNPs studied in conditional analyses. Haploview diagram displays increasing red with higher D’.
Three independently significant RA SNPs and HLA-DRB1 locations are indicated.
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Previous studies of MHC effects on RA susceptibility
beyond the SE have identified additional independent
signals but have been largely inconsistent, due at least in
part to the difficulty of narrowing down regions of
association in the presence of extended LD [1,13].
Multiple studies have implicated the TNF-lymphotoxin
locus in class III [1], which were not significant in our
conditional analysis. Other studies also using NARAC
cases have observed signals in class I [5,14], including
HLA-C, our second SNP added in conditional analysis.
Our first SNP is in the gene TRIM39, also in class I but
not previously implicated. Our third SNP, in class II, is
150 kb upstream from HLA-DRB1 between the BTNL2
and HLA-DRA genes. BTNL2 has been associated with
RA, systemic lupus erythematosus, and type 1 diabetes
[15]; this is attributed to its association with predispos-
ing HLA DQB1-DRB1 haplotypes, which may explain its
presence in our data as well.
It is important to note that the NARAC population is
primarily Caucasian. Other populations could have
quite different distributions of these haplotypes as well
as other haplotypes and allele frequencies. A similar
analysis in other ethnic groups could be very informa-
tive.
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